Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Propiverine Hydrochloride
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Propiverine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder, Neurogenic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 10, 2012
Lead Product(s) : Propiverine Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Propiverine Hydrochloride
Therapeutic Area : Urology
Study Phase : Phase III
Recipient : Lee Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder
Details : Propiverine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder, Overactive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 19, 2012
Lead Product(s) : Propiverine Hydrochloride
Therapeutic Area : Urology
Highest Development Status : Phase III
Recipient : Lee Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable